Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-22

FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)

View source ↗

Summary

FDA approved a supplemental application for Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) from Janssen Products LP. The approval upd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)

Snippet

SUPPL AP for SYMTUZA (DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE)